<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2002</study_start_year><data_sharing_plan>IPD Sharing (as of September 2019): Yes
Description: http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf
URL: http://engagezone.msd.com/ds_documentation.php</data_sharing_plan><condition>Adenomatous Polyposis Coli</condition><condition>Colorectal Neoplasms</condition><condition>Nasopharyngeal Neoplasms</condition><condition>Osteoarthritis</condition><disease>Adenomatous Polyposis Coli</disease><disease>Colorectal Neoplasms</disease><disease>Nasopharyngeal Neoplasms</disease><disease>Osteoarthritis</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2015062</full_dataset_link><study_start_month>8</study_start_month><keyword>Rofecoxib</keyword><keyword>Cancer Pain</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)</name><description>A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.</description><dates><creation>2002-08-15</creation></dates><accession>2015062</accession><cross_references><ClinicalTrials___gov>NCT00140894</ClinicalTrials___gov></cross_references></HashMap>